Insulin resistance (IR) in skeletal muscle is a key defect mediating the link between obesity
and type 2 33 diabetes, a disease that typically affects people in later life. Sarcopenia (age …

Sarcopenia is a common muscular affection among elderly individuals. More recently, it has
been recognized as the skeletal muscle (SM) expression of the metabolic syndrome. The …

Sarcopenia is a multifactorial disease characterized by reduced muscle mass and function,
leading to disability, death, and other diseases. Recently, the prevalence of sarcopenia …

Skeletal muscle maintains our posture and produces body movement. Muscle is essential to
make all movements required in daily life. Skeletal muscle has several other roles. It is a …

Sarcopenia in geriatric patients is often associated with or even caused by changes of the
endocrine and nervous system. The multifactorial pathogenesis of sarcopenia and …

Sarcopenia is defined as the age-related loss of muscle mass and strength or physical
performance. Increased amounts of adipose tissue often accompany sarcopenia, a condition …

The prevalence of obesity in combination with sarcopenia (the age-related loss of muscle
mass and strength or physical function) is increasing in adults aged 65 years and older. A …

The incidence and prevalence of metabolic and musculoskeletal diseases are increasing.
Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation …

Sarcopenic obesity, a chronic condition, is today a major public health problem with
increasing prevalence worldwide, which is due to progressively aging populations, the …

Age‐associated obesity and muscle atrophy (sarcopenia) are intimately connected and are
reciprocally regulated by adipose tissue and skeletal muscle dysfunction. During ageing …